Partner Keerthika Subramanian Selected to Serve on the Food and Drug Law Institute’s Food and Drug Law Journal 2025 Editorial Advisory Board

Winston & Strawn partner Keerthika Subramanian has been selected to serve on the Food and Drug Law Institute’s 2025 Food and Drug Law Journal Editorial Advisory Board—a peer-reviewed quarterly devoted to the analysis of legislation, regulations, court decisions, and public policies affecting industries regulated by the U.S. Food and Drug Administration and related agencies and authorities, including the development, manufacture, marketing, and use of drugs, medical devices, biologics, food, dietary supplements, cosmetics, veterinary, tobacco, and cannabis-derived products. 

Members of the board, chosen based on their background, experience, and engagement with FDLI, review and evaluate submitted articles, providing substantive feedback in a peer review process for the journal.

Learn more about the Food and Drug Law Institute.